Propofol Withdrawal Dyskinesia in a Parkinson's Disease Patient with Levodopa-Induced Dyskinesia

被引：0
|
作者：
Nakajima, Asuka [1 ,2 ]
Iwamuro, Hirokazu [3 ]
Tokugawa, Joji [4 ]
Odo, Masahiko [5 ]
Shimo, Yasushi [1 ,2 ]
机构：
[1] Juntendo Univ Nerima Hosp, Dept Neurol, Tokyo, Japan
[2] Juntendo Univ, Sch Med, Dept Res & Therapeut Movement Disorders, Tokyo, Japan
[3] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo, Japan
[4] Juntendo Univ Nerima Hosp, Dept Neurosurg, Tokyo, Japan
[5] Juntendo Univ Nerima Hosp, Dept Anesthesia & Pain Med, Tokyo, Japan
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2023年 / 50卷 / 02期
基金：
日本学术振兴会;
关键词：
Dyskinesia; Propofol; Parkinson's disease; Deep brain stimulation; Cortico-basal ganglia circuits; DOPAMINE TURNOVER;
D O I：
10.1017/cjn.2022.4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
  • [31] Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease
    Alessandra Nicoletti
    Giovanni Mostile
    Giuseppe Nicoletti
    Gennarina Arabia
    Giovanni Iliceto
    Paolo Lamberti
    Roberto Marconi
    Letterio Morgante
    Paolo Barone
    Aldo Quattrone
    Mario Zappia
    Journal of Neurology, 2016, 263 : 888 - 894
  • [32] Pathophysiology of levodopa-induced dyskinesia in Parkinson's disease: A TMS study
    Morgante, F
    Espay, AJ
    Gunraj, C
    Lang, AE
    Chen, R
    MOVEMENT DISORDERS, 2005, 20 (09) : 1238 - 1238
  • [33] Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease
    Santos-Lobato, Bruno Lopes
    Schumacher-Schuh, Artur F.
    Rieder, Carlos R. M.
    Hutz, Mara H.
    Borges, Vanderci
    Ferraz, Henrique Ballalai
    Mata, Ignacio F.
    Zabetian, Cyrus P.
    Tumas, Vitor
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2020, 78 (04) : 206 - 216
  • [34] Levodopa-induced dyskinesia in Parkinson's disease: Epidemiology, etiology, and treatment
    Zesiewicz, Theresa A.
    Sullivan, Kelly L.
    Hauser, Robert A.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2007, 7 (04) : 302 - 310
  • [35] Chemical management of levodopa-induced dyskinesia in Parkinson's disease patients
    Dragasevic-Miskovic, Natasa
    Petrovic, Igor
    Stankovic, Iva
    Kostic, Vladimir S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 219 - 230
  • [36] A Web Resource for Levodopa-Induced Dyskinesia Genetics in Parkinson’s Disease
    Hagen Blankenburg
    Marika Falla
    Christine Schwienbacher
    Giovanni Fabbrini
    Alfredo Berardelli
    Peter P. Pramstaller
    Francisco S. Domingues
    Neuroinformatics, 2017, 15 : 297 - 300
  • [37] Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
    Espay, Alberto J.
    Morgante, Francesca
    Merola, Aristide
    Fasano, Alfonso
    Marsili, Luca
    Fox, Susan H.
    Bezard, Erwan
    Picconi, Barbara
    Calabresi, Paolo
    Lang, Anthony E.
    ANNALS OF NEUROLOGY, 2018, 84 (06) : 797 - 811
  • [38] Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia
    Su, Dongning
    Gan, Yawen
    Zhang, Zhe
    Cui, Yusha
    Zhang, Zhijin
    Liu, Zhu
    Wang, Zhan
    Zhou, Junhong
    Sossi, Vesna
    Stoessl, A. Jon
    Wu, Tao
    Jing, Jing
    Feng, Tao
    MOVEMENT DISORDERS, 2023, 38 (04) : 616 - 625
  • [39] Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: A pilot study
    Sieradzan, KA
    Fox, SH
    Hill, M
    Dick, JPR
    Crossman, AR
    Brotchie, JM
    NEUROLOGY, 2001, 57 (11) : 2108 - 2111
  • [40] Assessment of Parkinson’s disease levodopa-induced dyskinesia: a qualitative research study
    William R. Lenderking
    Sally Mannix
    Jennifer Petrillo
    Christopher Kenney
    Amanda Landrian
    Anette-Eleonore Schrag
    Quality of Life Research, 2015, 24 : 1899 - 1910
12345